EB-576

N/A

Report date: 2025/01/26 16:27:27
NME

Base Information

Drug NameEB-576
Drug Alias NameEB-576
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionS-adenosylmethionine synthase isoform type-2 inhibitors
TargetsS-adenosylmethionine synthase isoform type-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEuregen Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEuregen Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A